G. Voetberg

Dose-response characteristics for arginine-stimulated insulin secretion in man and influence of hyperglycemia.

T. W. Haeften, J. Gerich, E. A. van der Veen, 1989, The Journal of clinical endocrinology and metabolism.

Micturition complaints in postmenopausal women treated with continuously combined hormone replacement therapy: a prospective study.

P. Kenemans, C. Burger, G. Voetberg, 1999, Maturitas.

Estrogen replacement therapy continuously combined with four different dosages of dydrogesterone: effect on calcium and lipid metabolism.

P. Kenemans, J. C. Netelenbos, G. Voetberg, 1994, The Journal of clinical endocrinology and metabolism.

Oral 17β-Estradiol Continuously Combined with Dydrogesterone Lowers Serum Lipoprotein(a) Concentrations in Healthy Postmenopausal Women1

P. Kenemans, J. C. Netelenbos, G. Kamp, 1997 .

Continuously combined hormone replacement therapy and bone turnover: the influence of dydrogesterone dose, smoking and initial degree of bone turnover.

P. Kenemans, J. C. Netelenbos, C. Popp‐Snijders, 1997, Maturitas.

Oral 17 beta-estradiol continuously combined with dydrogesterone lowers serum lipoprotein(a) concentrations in healthy postmenopausal women.

P. Kenemans, J. C. Netelenbos, G. V. van Kamp, 1997, Journal of Clinical Endocrinology and Metabolism.

Growth hormone release after the sequential use of growth hormone releasing factor and exercise.

J. H. de Vries, G. Voetberg, E. van der Veen, 1991, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.